Condition
Symptomatic Dermographism clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Symptomatic Dermographism clinical trials that are recruiting, at sites in 7 countries (most in Germany (2), Lithuania (1), Poland (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 7Countries
All recruiting trials (2)
-
Barzolvolimab versus placebo for adults with cold-induced urticaria and symptomatic dermographism not controlled by H1-antihistamines
This trial will test whether barzolvolimab can reduce hives and itching in adults with cold-induced urticaria or symptomatic dermographism who remain symptomatic despite H1-antihistamines.
-
GTX-B001 in healthy people and adults with chronic inducible urticaria
This will test a single intravenous dose of GTX-B001, a bispecific antibody, in healthy volunteers and in adults with chronic inducible urticaria (cold urticaria or symptomatic dermographism) who still have symptoms despite antihistamines.
Related topics
Quick answers
How many Symptomatic Dermographism clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Germany (2 trials), Lithuania (1 trial), Poland (1 trial), South Africa (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.